The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma

Journal of Cellular Biochemistry

Volumn 102, Issue 4, 2007, Pages 1002-1010

  Hahm, Eunsil ^a   Jin, Dong Hoon ^b   Jae, Seung Kang ^a   Kim, Young In ^a   Hong, Seung Woo ^b   Seung, Koo Lee ^a   Ha, Na Kim ^a   Da, Jung Jung ^a   Jee, Eun Kim ^a   Dong, Hoon Shin ^a   Young, Il Hwang ^a   Yeong, Seok Kim ^c   Dae, Young Hur ^c   Yang, Yoolhee ^b   Cho, Daeho ^b   Lee, Myeong Sok ^b   Wang, Jae Lee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

CDK2; Chk2; G1 arrest; Melanoma; p21Waf1 Cip1; p53; Vitamin C

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ASCORBIC ACID; ATM PROTEIN; ATR PROTEIN; CAFFEINE; CELL DNA; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROPIDIUM IODIDE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASCORBIC ACID; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; MELANOMA, EXPERIMENTAL; MICE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 35649024852     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21336     Document Type: Article

References (34)

1. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal W. 2003. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22:8271-8282.
2. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
3. Bram S, Froussard P, Guichard M, Jasmin C, Augery Y, Sinoussi-Barre F, Wray W. 1980. Vitamin C preferential toxicity for malignant melanoma cells. Nature 28:629-631.
4. Buzaid AC, Legha SS. 1994. Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of advanced melanoma. Semin Oncol 21:23-28.
5. Chehab NH, Malikzay A, Appel M, Halazonetis TD. 2000. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 14:278-288.
6. Cho D, Hahm E, Kang JS, Kim YI, Yang Y, Park JH, Kim D, Kim S, Kim YS, Hur D, Park H, Pang S, Hwang YI, Lee WJ. 2003. Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells. Melanoma Res 13:549-554.
7. Cho D, Song H, Kim YM, Houh D, Hur DY, Park HJ, Yoon D, Pyun KH, Lee WJ, Kurimoto M, Kim YB, Kim YS, Choi I. 2000. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res 60:2703-2709.
8. Cordon-Cardo C. 1995. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147:545-560.
9. Fei P, Bernard EJ, Deiry WS. 2003. p53 and radiation responses. Oncogene 22:5774-5783.
10. Fingar DC, Blenis J. 2004. Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171.
11. Fridman JS, Lowe SW. 2003. Control of apoptosis by p53. Oncogene 22:9030-9040.
12. Hemila H. 1992. Vitamin C and the common cold. Br J Nutr 67:3-16.
13. Jack MT, Woo RA, Hirao A, Cheung A, Mak TW, Lee PW. 2002. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proc Natl Acad Sci USA 99:9825-9829.
14. Jamison JM, Gilloteaux J, Nassiri MR, Venugopal M, Neal DR, Summers JL. 2004. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following Vitamin C and Vitamin K3 treatment. Biochem Pharmacol 67:337-351.
15. Jeng KC, Yang CS, Siu WY, Tsai YS, Liao WJ, Kuo JS. 1996. Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults. Am J Clin Nutr 64:960-965.
16. Kang JS, Cho D, Kim YI, Hahm E, Kim YS, Jin SN, Kim HN, Kim D, Hur D, Park H, Hwang YI, Lee WJ. 2005. Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake. J Cell Physiol 204:192-197.
17. Kang JS, Cho D, Kim YI, Hahm E, Yang Y, Kim D, Hur D, Park H, Bang S, Hwang YI, Lee WJ. 2003. L-ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8-independent pathway. Cancer Immunol Immunother 52:693-698.
18. Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316-323.
19. Legha SS, Ring S, Bedikian A, Plager C, Eton O, Buzaid AC, Papadopoulos N. 1996. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann Oncol 7:827-835.
20. Levine M. 1986. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 314:892-902.
21. Levine M. 1995. Determination of optimal vitamin C requirements in humans. Am J Clin Nutr 62(Suppl 6):1347-1356.
22. Obana K, Yang HW, Piao HY, Taki T, Hashizume K, Hanada R, Yamamoto K, Tanaka Y, Toyoda Y, Takita J, Tsuchida Y, Hayashi Y. 2003. Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors. Int J Oncol 23:1151-1157.
23. Peter M, Herskowitz I. 1994. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
24. Ryan KM, Pillips AC, Vousden KH. 2001. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13:332-337.
25. Schwartz JL. 1996. The dual roles of nutrients as antioxidants and prooxidants: Their effects on tumor cell growth. J Nutr 126(Suppl 4):1221-1227.
26. Sherr CJ. 1994. Gl phase progression: Cycling on cue. Cell 79:551-555.
27. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
28. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
29. Sies H, Stahl W. 1995. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62(Suppl 6):1315-1321.
30. Sun W, Schuchter LM. 2001. Metastatic melanoma. Curr Treat Options Oncol 2:193-202.
31. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13:152-157.
32. Wesley UV, Tiwari S, Houghton AN. 2004. Role for dipeptidyl peptidase TV in tumor suppression of human nonsmall cell lung carcinoma cells. Int J Cancer 109:855-866.
33. Wu G, Fan RS, Li W, Ko TC, Brattain MG. 1997. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene 15:1555-1563.
34. waf1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11:103-113.